A Phase II Single Arm Proof Of Concept, Safety, Efficacy, Multicenter Study Of Brentuximab Vedotin As Consolidation Therapy After Autologous Stem Cell Transplant In CD 30 Expressing Peripheral T Cell Lymphomas BRENTICON-T

Brief Summary

Type:
Lymphomas

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT04334174

Study #:
STUDY00145258

Start Date:
Mar 23, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04334174

View Complete Trial Details & Eligibility at ClinicalTrials.gov